Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

New FDA framework tilts toward consistency over flexibility

Then-acting FDA leaders said over the summer that regulatory flexibility wasn't the standard they were striving for when the agency gauges rare disease drugs. Now, a more consistent system for assessing

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Wednesday 14 October →